Print Friendly, PDF & Email

NCT/Study#

NCT03149003 /

BBI-DSP7888-201G

A Randomized, Multicenter, Phase 2 Study Of DSP-7888 Dosing Emulsion In Combination With Bevacizumab Versus Bevacizumab Alone In Patients With Recurrent Or Progressive Glioblastoma Following Initial Therapy

DISEASE GROUP:

Neuro-Oncology

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587